News & Events Press Releases Events & Presentations Year None20212020201920182017 07.07 2021 Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 06.22 2021 Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of mRNA Influenza Vaccine 06.09 2021 Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 06.07 2021 Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program 05.24 2021 Translate Bio to Participate in Upcoming Investor Conferences 05.18 2021 Translate Bio Presents Preclinical Results in Primary Ciliary Dyskinesia (PCD) at American Thoracic Society (ATS) 2021 International Conference 05.06 2021 Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update 05.05 2021 Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 04.28 2021 Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit 04.20 2021 Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 22 Presentations Corporate Presentation 15.3 MB Upcoming Events More events are coming soon. Past Events 07.15 2021 1:00 PM EDT William Blair Biotech Focus Virtual Conference 06.22 2021 2:00 PM EDT SVB Leerink 2nd Annual CybeRx Series: Vaccine Forum 06.08 2021 3:50 PM EDT Goldman Sachs 42nd Annual Global Healthcare Conference 06.03 2021 10:30 AM EDT Jefferies Virtual Healthcare Conference 05.05 2021 10:30 AM EDT 7th Annual Truist Securities Life Sciences Summit 03.17 2021 4:30 PM EDT Translate Bio MRT5005 Second Interim Data Analysis Conference Call
